Skip to content
10-Q

Quarterly Report

Raphael Pharmaceutical Inc. RAPH

0001213900-24-043557

← back to feed
Filed
May 15, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 15, 2024 18.66M sh
Cash And Equivalents Q1 2024 · Mar 31, 2024 $287K
Cash And Equivalents Q1 2024 · Dec 31, 2023 $230K
Current Liabilities Q1 2024 · Mar 31, 2024 $456K
Current Liabilities Q1 2024 · Dec 31, 2023 $72K
Current Assets Q1 2024 · Mar 31, 2024 $350K
Current Assets Q1 2024 · Dec 31, 2023 $337K
Total Assets Q1 2024 · Mar 31, 2024 $353K
Total Assets Q1 2024 · Dec 31, 2023 $339K
Shares Diluted Q1 2024 · Mar 31, 2023 15.96M sh
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$399K
Stockholders Equity Q1 2024 · Mar 31, 2023 −$9K
Stockholders Equity Q1 2024 · Dec 31, 2022 $106K
Eps Diluted Q1 2024 · Mar 31, 2023 $0.02
Eps Basic Q1 2024 · Mar 31, 2023 $0.02
Sga Expense Q1 2024 · Mar 31, 2023 $144K
Rd Expense Q1 2024 · Mar 31, 2023 $114K
Net Income Q1 2024 · Mar 31, 2023 −$264K
Operating Income Q1 2024 · Mar 31, 2023 −$258K